Novo Nordisk aims to launch more than five blockbuster drugs by 2030: CEO ...Middle East

Business Standard - Economy
Novo Nordisk aims to launch more than five blockbuster drugs by 2030: CEO
The company is racing ​to reassure markets that ​it can navigate patent expirations for semaglutide - the active ingredient in its anti-obesity ​drugs Ozempic and Wegovy franchises, in the early 2030s

Hence then, the article about novo nordisk aims to launch more than five blockbuster drugs by 2030 ceo was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk aims to launch more than five blockbuster drugs by 2030: CEO )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News